Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.67 USD | -8.25% |
|
+11.28% | -58.16% |
06-26 | EyePoint Pharmaceuticals, Inc. Highlights Duravuyu Clinical and Regulatory Progress and Pipeline Innovation At R&D Day 2024 | CI |
06-26 | Transcript : EyePoint Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.16% | 504M | |
+55.35% | 815B | |
+32.19% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.17% | 247B | |
+14.09% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Sector Update: Health Care Stocks Extending Monday Slide